Will Johnson & Johnson Be a Better Buy After Spinning Off Its Consumer Business?
Johnson & Johnson (NYSE: JNJ) announced last year that it would be spinning off its consumer health business. The separation, which could take as long as 24 months to complete, will leave shareholders with some important decisions to make. Among them: Should they remain invested in both companies, one of them, or neither?
Let's take a closer look at whether the spinoff is a good move for the business, why the company is likely doing it, and if investors will be better off in the long run.
Source Fool.com
